Pre-Seed, Seed
$250K – $1.5M
8+ companies
3 partners
Investment Thesis
Dedicated to supporting the growth of novel mental health solutions through psychedelics and therapy innovation.
Meet the Team
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (8)
Other
MindMed
Field Trip Health
Enthea
Mental health company dedicated to providing access to safe and affordable psychedelic-assisted therapy, beginning with ketamine therapy.
ProNovo
ProNovo Therapeutics, leveraging emerging science and cutting-edge technology, to develop novel, precision therapeutics to address urgent unmet needs in the treatment of neuropsychiatric disorders such as Major Depressive Disorder and Schizophrenia.
Psilera Bioscience
Reimagines psychoactive natural products as the building blocks for the next generation of neurological products.
Tripp
An award-winning breakthrough wellness platform.
Immunis Biomedical
Immunis is a clinical-stage biotech company developing multi-active biologics with immune modulating factors that can address age-related diseases and immune dysregulation.
Gilgamesh
A clinical-stage neuroscience biotech transforming the treatment paradigm of psychiatric diseases.
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Other — the sectors they actively back.
- •Size your ask to their typical $250K – $1.5M check.
- •cold outreach ok
- •Address your outreach to a specific partner, such as Simeon Schnapper, Managing Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if JLS Fund is a match for your startup
Upload your pitch deck to see how well you match with JLS Fund and 10,000+ other investors.
Is this your profile? Request a correction or removal